blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3431991

EP3431991 - KIT AND METHOD FOR MEASURING PROSTAGLANDIN E-MAJOR URINARY METABOLITE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.06.2022
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  09.07.2021
FormerGrant of patent is intended
Status updated on  28.02.2021
FormerRequest for examination was made
Status updated on  21.12.2018
FormerThe international publication has been made
Status updated on  22.09.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
Fujirebio Inc.
1-1 Nishishinjuku 2-chome
Shinjuku-ku
Tokyo 163-0410 / JP
[2019/04]
Inventor(s)01 / KATAGIRI, Noriko
c/o Advanced Life Science Institute Inc.
51 Komiya-machi
Hachioji-shi Tokyo 192-0031 / JP
02 / YAGI, Shintaro
c/o Advanced Life Science Institute Inc.
51 Komiya-machi
Hachioji-shi Tokyo 192-0031 / JP
 [2019/04]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2021/32]
Former [2019/04]Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date17766612.013.03.2017
[2019/04]
WO2017JP09963
Priority number, dateJP2016004996114.03.2016         Original published format: JP 2016049961
[2019/04]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017159612
Date:21.09.2017
Language:JA
[2017/38]
Type: A1 Application with search report 
No.:EP3431991
Date:23.01.2019
Language:EN
[2019/04]
Type: B1 Patent specification 
No.:EP3431991
Date:11.08.2021
Language:EN
[2021/32]
Search report(s)International search report - published on:JP21.09.2017
(Supplementary) European search report - dispatched on:EP18.09.2019
ClassificationIPC:G01N33/53, G01N33/543, G01N33/88
[2019/04]
CPC:
G01N33/88 (EP,US); G01N33/54393 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/04]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:KIT UND VERFAHREN ZUR MESSUNG DES PROSTAGLANDIN-E-HAUPTURINMETABOLITS[2019/04]
English:KIT AND METHOD FOR MEASURING PROSTAGLANDIN E-MAJOR URINARY METABOLITE[2019/04]
French:TROUSSE ET PROCÉDÉ DE MESURE DE MÉTABOLITE URINAIRE MAJEUR DE PROSTAGLANDINE E[2019/04]
Entry into regional phase20.09.2018Translation filed 
27.09.2018National basic fee paid 
27.09.2018Search fee paid 
27.09.2018Designation fee(s) paid 
27.09.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
27.09.2018Examination requested  [2019/04]
14.04.2020Amendment by applicant (claims and/or description)
01.03.2021Communication of intention to grant the patent
06.07.2021Fee for grant paid
06.07.2021Fee for publishing/printing paid
06.07.2021Receipt of the translation of the claim(s)
Opposition(s)12.05.2022No opposition filed within time limit [2022/29]
Fees paidRenewal fee
30.09.2018Renewal fee patent year 03
12.03.2020Renewal fee patent year 04
25.03.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.03.2017
AL11.08.2021
AT11.08.2021
CY11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
MK11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
TR11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
IE13.03.2022
LU13.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
[2024/29]
Former [2024/23]HU13.03.2017
AL11.08.2021
AT11.08.2021
CY11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
MK11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
IE13.03.2022
LU13.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2024/20]HU13.03.2017
AL11.08.2021
AT11.08.2021
CY11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
IE13.03.2022
LU13.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2024/18]HU13.03.2017
AL11.08.2021
AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
IE13.03.2022
LU13.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/10]AL11.08.2021
AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
IE13.03.2022
LU13.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/09]AL11.08.2021
AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
IE13.03.2022
LU13.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/08]AL11.08.2021
AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
IE13.03.2022
LU13.03.2022
Former [2022/47]AL11.08.2021
AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/36]AL11.08.2021
AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/29]AL11.08.2021
AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/25]AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/24]AT11.08.2021
CZ11.08.2021
DK11.08.2021
EE11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
NL11.08.2021
PL11.08.2021
RO11.08.2021
RS11.08.2021
SE11.08.2021
SK11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/21]AT11.08.2021
DK11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
NL11.08.2021
PL11.08.2021
RS11.08.2021
SE11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/16]AT11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
NL11.08.2021
PL11.08.2021
RS11.08.2021
SE11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/10]AT11.08.2021
ES11.08.2021
FI11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
PL11.08.2021
RS11.08.2021
SE11.08.2021
BG11.11.2021
NO11.11.2021
GR12.11.2021
IS11.12.2021
PT13.12.2021
Former [2022/09]AT11.08.2021
ES11.08.2021
FI11.08.2021
LT11.08.2021
RS11.08.2021
SE11.08.2021
BG11.11.2021
NO11.11.2021
PT13.12.2021
Former [2022/08]AT11.08.2021
ES11.08.2021
FI11.08.2021
LT11.08.2021
SE11.08.2021
BG11.11.2021
NO11.11.2021
Former [2022/07]AT11.08.2021
LT11.08.2021
NO11.11.2021
Documents cited:Search[Y]EP0166583  (ONO PHARMACEUTICAL CO [JP]) [Y] 1-15 * example 2 *;
 [Y]EP1870708  (FUJIREBIO KK [JP], et al) [Y] 1-15 * example 1 *;
 [Y]  - INAGAWA T ET AL, "SIMPLIFIED IMMUNOASSAYS OF PROSTAGLANDIN E MAIN METABOLITE IN HUMAN URINE", ADVANCES IN PROSTAGLANDIN, THROMBOXANE, AND LEUKOTRIENE RESEARCH 5TH INTERNATIONAL PROSTAGLANDIN CONFERENCE; FLORENCE, ITALY, MAY 18-21, 1982,, (19830521), vol. 11, pages 191 - 196, XP009104268 [Y] 1-15 * page 192 - page 193 *
International search[A]JPS6111664  (ONO PHARMACEUTICAL CO) [A] 1-15* , examples 1, 2 & EP 166583 A2 examples 1, 2 *;
 [A]WO2006118004  (FUJIREBIO KK [JP], et al) [A] 1-15 * , example 1 & US 2009/0130775 A1 example 1 & EP 1870708 A1 & CA 2605152 A1 & CN 101133323 A *;
 [A]  - SATORU ITO et al., "In regard to urinary PGE- MUM : interstitial pneumonia", The Cell, (20131120), vol. 45, no. 12, ISSN 1346-7557, pages 581 - 584, XP009513884 [A] 1-15
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.